BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 23337036)

  • 21. Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth.
    Pu P; Zhang Z; Kang C; Jiang R; Jia Z; Wang G; Jiang H
    Cancer Gene Ther; 2009 Apr; 16(4):351-61. PubMed ID: 18949017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wnt3a regulates proliferation, apoptosis and function of pancreatic NIT-1 beta cells via activation of IRS2/PI3K signaling.
    Gui S; Yuan G; Wang L; Zhou L; Xue Y; Yu Y; Zhang J; Zhang M; Yang Y; Wang DW
    J Cell Biochem; 2013 Jul; 114(7):1488-97. PubMed ID: 23296977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells.
    Kim KH; Seol HJ; Kim EH; Rheey J; Jin HJ; Lee Y; Joo KM; Lee J; Nam DH
    Neuro Oncol; 2013 Feb; 15(2):161-71. PubMed ID: 23258844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction and down-regulation of Sox17 and its possible roles during the course of gastrointestinal tumorigenesis.
    Du YC; Oshima H; Oguma K; Kitamura T; Itadani H; Fujimura T; Piao YS; Yoshimoto T; Minamoto T; Kotani H; Taketo MM; Oshima M
    Gastroenterology; 2009 Oct; 137(4):1346-57. PubMed ID: 19549530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wnt3a stimulates Mepe, matrix extracellular phosphoglycoprotein, expression directly by the activation of the canonical Wnt signaling pathway and indirectly through the stimulation of autocrine Bmp-2 expression.
    Cho YD; Kim WJ; Yoon WJ; Woo KM; Baek JH; Lee G; Kim GS; Ryoo HM
    J Cell Physiol; 2012 Jun; 227(6):2287-96. PubMed ID: 22213482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moesin is a glioma progression marker that induces proliferation and Wnt/β-catenin pathway activation via interaction with CD44.
    Zhu X; Morales FC; Agarwal NK; Dogruluk T; Gagea M; Georgescu MM
    Cancer Res; 2013 Feb; 73(3):1142-55. PubMed ID: 23221384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysregulation of Fra1 expression by Wnt/β-catenin signalling promotes glioma aggressiveness through epithelial-mesenchymal transition.
    Zhang L; Liu H; Mu X; Cui J; Peng Z
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28232512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wnt inhibition is dysregulated in gliomas and its re-establishment inhibits proliferation and tumor sphere formation.
    Kierulf-Vieira KS; Sandberg CJ; Grieg Z; Günther CC; Langmoen IA; Vik-Mo EO
    Exp Cell Res; 2016 Jan; 340(1):53-61. PubMed ID: 26712519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sohlh1 suppresses glioblastoma cell proliferation, migration, and invasion by inhibition of Wnt/β-catenin signaling.
    Liu X; Gao Q; Zhao N; Zhang X; Cui W; Sun J; Fu J; Hao J
    Mol Carcinog; 2018 Apr; 57(4):494-502. PubMed ID: 29240260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RYK promotes the stemness of glioblastoma cells via the WNT/ β-catenin pathway.
    Adamo A; Fiore D; De Martino F; Roscigno G; Affinito A; Donnarumma E; Puoti I; Ricci Vitiani L; Pallini R; Quintavalle C; Condorelli G
    Oncotarget; 2017 Feb; 8(8):13476-13487. PubMed ID: 28086236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Small-Molecule Antagonist of the β-Catenin/TCF4 Interaction Blocks the Self-Renewal of Cancer Stem Cells and Suppresses Tumorigenesis.
    Fang L; Zhu Q; Neuenschwander M; Specker E; Wulf-Goldenberg A; Weis WI; von Kries JP; Birchmeier W
    Cancer Res; 2016 Feb; 76(4):891-901. PubMed ID: 26645562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IGFBP2 promotes glioma tumor stem cell expansion and survival.
    Hsieh D; Hsieh A; Stea B; Ellsworth R
    Biochem Biophys Res Commun; 2010 Jun; 397(2):367-72. PubMed ID: 20515648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas.
    Hendrix ND; Wu R; Kuick R; Schwartz DR; Fearon ER; Cho KR
    Cancer Res; 2006 Feb; 66(3):1354-62. PubMed ID: 16452189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wnt/beta-catenin signaling in cancer stemness and malignant behavior.
    Fodde R; Brabletz T
    Curr Opin Cell Biol; 2007 Apr; 19(2):150-8. PubMed ID: 17306971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HSulf-1 inhibits cell proliferation and invasion in human gastric cancer.
    Li J; Mo ML; Chen Z; Yang J; Li QS; Wang DJ; Zhang H; Ye YJ; Li HL; Zhang F; Zhou HM
    Cancer Sci; 2011 Oct; 102(10):1815-21. PubMed ID: 21722266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of RND3/RhoE in glioblastoma patients promotes tumorigenesis through augmentation of notch transcriptional complex activity.
    Liu B; Lin X; Yang X; Dong H; Yue X; Andrade KC; Guo Z; Yang J; Wu L; Zhu X; Zhang S; Tian D; Wang J; Cai Q; Chen Q; Mao S; Chen Q; Chang J
    Cancer Med; 2015 Sep; 4(9):1404-16. PubMed ID: 26108681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteins of the Wnt signaling pathway as targets for the regulation of CD133+ cancer stem cells in glioblastoma.
    Shevchenko V; Arnotskaya N; Korneyko M; Zaytsev S; Khotimchenko Y; Sharma H; Bryukhovetskiy I
    Oncol Rep; 2019 May; 41(5):3080-3088. PubMed ID: 30864699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner.
    Wiese M; Walther N; Diederichs C; Schill F; Monecke S; Salinas G; Sturm D; Pfister SM; Dressel R; Johnsen SA; Kramm CM
    Oncotarget; 2017 Apr; 8(16):27300-27313. PubMed ID: 28460484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.